Study of AAV-GAD Gene Transfer Into the Subthalamic Nucleus for Parkinson's Disease
Clinical trial NCT00643890 · TERMINATED
Trial details
- NCT number
- NCT00643890
- Sponsor
- Neurologix, Inc.
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2008-08-01
- Primary completion
- 2010-12-01
- Enrollment
- 44
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.